Efficacy and safety of radioligand therapy in a 76-year-old patient with metastatic grade 2 pancreatic neuroendocrine tumor

Authors

Institutions

Publication Details

Journal
Endokrynologia Polska
Published
2025-12-03
DOI
https://doi.org/10.5603/ep.109778
Primary Topic
Neuroendocrine Tumor Research Advances
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of radioligand therapy in a 76-year-old patient with metastatic grade 2 pancreatic neuroendocrine tumor

Beata Kos‐Kudła, Anna Zemczak, Olgierd Chrabański
Endokrynologia Polska
Neuroendocrine Tumor Research Advances
article

Efficacy and safety of radioligand therapy in a 76-year-old patient with metastatic grade 2 pancreatic neuroendocrine tumor

Beata Kos‐Kudła, Anna Zemczak, Olgierd Chrabański
article en

Abstract

No abstract available for this paper.
Endokrynologia PolskaVol. 76(6)
Medical University of Silesia (PL)
Openalex Percentile: Top 50%
Neuroendocrine Tumor Research Advances
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy and safety of radioligand therapy in a 76-year-old patient with metastatic grade 2 pancreatic neuroendocrine tumor — Beata Kos‐Kudła, Anna Zemczak, et al. · Endokrynologia Polska (2025) | TGRS Research Map | TGRS